C. Galloway

Temperature-sensitive beta-lactam-tolerant mutants of Escherichia coli.

E. Ishiguro, L. Shimmin, D. Vanderwel, 1984, Journal of general microbiology.

Pharmacokinetics of hepatitis C virus NS5A inhibitor JNJ‐56914845 (GSK2336805) in subjects with hepatic impairment

William Smith, K. Adkison, T. Marbury, 2015, Journal of clinical pharmacology.

Baricitinib in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial and updated meta-analysis

K. C. Morris, Mohammed Salah Ibrahim, K. Y. Wong, 2022, medRxiv.

Tocilizumab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial

Steve B Jones, K. Y. Wong, Chamil H. Hettiarachchi, 2021, Lancet.

Cefiderocol, a Siderophore Cephalosporin for Gram‐Negative Bacterial Infections: Pharmacokinetics and Safety in Subjects With Renal Impairment

R. Echols, H. Krenz, J. A. Arjona Ferreira, 2016, Journal of clinical pharmacology.

Efficacy, safety, and immunogenicity of a booster regimen of Ad26.COV2.S vaccine against COVID-19 (ENSEMBLE2): results of a randomised, double-blind, placebo-controlled, phase 3 trial

A. Borobia, H. Schuitemaker, Andrew Gibson, 2022, The Lancet Infectious Diseases.

Liver Transplantation for Severe Alcoholic Hepatitis: Report of a Single Center Pilot Program.

A. Christianson, V. Sundaram, M. Noureddin, 2018, Transplantation proceedings.